Financial News
Articles published by Merck & Co., Inc.
Merck Animal Health to Acquire Vence
September 22, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Receives Positive CHMP Opinion for VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) in Infants and Children
September 16, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Reports Strong Progress in ESG Focus Areas
August 30, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Receives Fast Track Designation from the U.S. FDA for MK-2060, an Investigational Anticoagulant Therapy
August 23, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck and Orna Therapeutics Collaborate to Advance Orna’s Next Generation of RNA Technology
August 16, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Announces Second-Quarter 2022 Financial Results
July 28, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Announces Fourth-Quarter 2022 Dividend
July 26, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.